Cocaine occupancy of sigma1 receptors and dopamine transporters in mice

Synapse

Volumn 70, Issue 3, 2016, Pages 98-111

  Lever, John R ^a,b   Fergason Cantrell, Emily A ^a,b   Watkinson, Lisa D ^a,b   Carmack, Terry L ^a,b   Lord, Sarah A ^a,b   Xu, Rong ^a   Miller, Dennis K ^a,c   Lever, Susan Z ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c University of Missouri   (United States)

Author keywords

Cocaine; Dopamine transporter; Locomotor activity; Mouse; Occupancy; Sigma receptor; Substance abuse

Indexed keywords

COCAINE; DEXTROMETHORPHAN; DOPAMINE TRANSPORTER; HALOPERIDOL; IFENPRODIL; IODINE 125; MOLECULAR LAYER; NALORPHINE; PENTAZOCINE; PIPERAZINE DERIVATIVE; RADIOLIGAND; SIGMA 1 OPIATE RECEPTOR; DOPAMINE UPTAKE INHIBITOR; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CAUDATE NUCLEUS; CD-1 MOUSE; CEREBELLUM; CEREBELLUM GRANULAR LAYER; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS CALLOSUM; DENSITY; DENTATE GYRUS; DIENCEPHALON; DOSE RESPONSE; ENTORHINAL CORTEX; EX VIVO STUDY; FRONTAL CORTEX; HEART; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; IC50; IN VIVO STUDY; INFERIOR COLLICULUS; LIGAND BINDING; LOCOMOTION; LUNG; MALE; MESENCEPHALON; METENCEPHALON; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PARIETAL CORTEX; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; RECEPTOR OCCUPANCY; SPLEEN; SUPERIOR COLLICULUS; TEMPORAL CORTEX; THALAMUS; THALAMUS NUCLEUS; WHITE MATTER; ANIMAL; BINDING COMPETITION; BRAIN; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, SIGMA;

EID: 84952705298     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21877     Document Type: Article

References (75)

1. Barr JL, Deliu E, Brailoiu GC, Zhao P, Yan G, Abood ME, Unterwald EM, Brailoiu E. 2015. Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1, 4, 5-trisphosphate-transient receptor potential canonical channel pathways. Cell Calcium 58:196-207.
2. 3H]DTG binding sites in guinea pig cerebellum: Evidence for the presence of non-specific binding. Eur J Pharmacol 252:139-146.
3. Benuck M, Lajtha A, Reith ME. 1987. Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243:144-149.
4. 125I]Iodophenyl)tropane-2 β -carboxylic acid isopropyl ester. Mol Pharm 47:779-786.
5. Bouchard P, Roman F, Junien J-L, Quirion R. 1996. Autoradiographic evidence for the modulation of in vivo sigma receptor labeling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain. J Pharmacol Exp Ther 276:223-230.
6. 3H](+)-Pentazocine: A potent and highly selective benzomorphan-based probe for sigma-1 receptors. Mol Neuropharmacol 3:117-126.
7. Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL. 2004. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers. J Med Chem 47:6401-6409.
8. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
9. 1 receptors of guinea pig brain. Synapse 55:192-195.
10. Desai RI, Kopajtic TA, French D, Newman AH, Katz JL. 2005. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-2-[bis-(4-fluorophenyl)methoxy]ethyl-4-(3-phenylpropyl)piperazine], and benztropine analogs. J Pharmacol Exp Ther 315:397-404.
11. Desai RI, Grandy DK, Lupica CR, Katz JL. 2014. Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist. J Pharmacol Exp Ther 348:106-115.
12. Fowler JS, Volkow ND, Logan J, Gatley SJ, Pappas N, King P, Ding YS, Wang GJ. 1998. Measuring dopamine transporter occupancy by cocaine in vivo: Radiotracer considerations. Synapse 28:111-116.
13. Fowler JS, Kroll C, Ferrieri R, Alexoff D, Logan J, Dewey SL, Schiffer W, Schlyer D, Carter P, King P, Shea C, Xu Y, Muench L, Benveniste H, Vaska P, Volkow ND. 2007. PET studies of d-methamphetamine pharmacokinetics in primates: Comparison with l-methamphetamine and (-)-cocaine. J Nucl Med 48:1724-1732.
14. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
15. Garcés-Ramírez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G. 2011. Sigma receptor agonists: Receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol Psychiatry 69:208-217.
16. Gatley SJ, Volkow ND, Fowler JS, Ding Y-S, Logan J, Wang G-J, Gifford AN. 2003. Positron emission tomography and its use to image the occupancy of drug binding sites. Drug Dev Res 59:194-201.
17. George FR. 1991. Cocaine toxicity: Genetic evidence suggests different mechanisms for cocaine-induced seizures and lethality. Psychopharmacol 104:307-311.
18. Golden GT, Ferraro TN, Smith GG, Snyder RL Jones NL., Berrettini. 2001. Acute cocaine-induced seizures: Differential sensitivity of six inbred mouse strains. Neuropsychopharmacol 24:291-299.
19. Grimwood S, Hartig PR. 2009. Target site occupancy: Emerging generalizations from clinical and preclinical studies. Pharmacol Ther 122:281-301.
20. Hayashi T, Su T-P. 2001. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci USA 98:491-496.
21. Hayashi T, Su T-P. 2005. The sigma receptor: Evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 3:267-280.
22. Heard K, Palmer R, Zahniser NR. 2008. Mechanisms of acute cocaine toxicity. Open Pharmacol J 2:70-78.
23. Hiranita T, Soto PL, Tanda G, Katz JL. 2010. Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine. J Pharmacol Exp Ther 332:515-524.
24. Hiranita T, Mereu M, Soto PL, Tanda G, Katz JL. 2013. Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology 38:605-615.
25. 11C]SA4503. Int J Neuropsychopharmacol 12:1127-1131.
26. Katz JL, Su T-P, Hiranita T, Hayashi T, Tanda G, Kopajtic T, Tsai SY. 2011. A role for sigma receptors in stimulant self administration and addiction. Pharmaceuticals (Basel) 4:880-914.
27. 11C]SA4503, by P-glycoprotein modulation. Synapse 48:80-86.
28. Kourrich S, Su T-P, Fujimoto M, Bonci A. 2012. The sigma-1 receptor: Roles in neuronal plasticity and disease. Trends Neurosci 35:762-771.
29. Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su T-P, Bonci A. 2013. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236-247.
30. Kovács KJ, Larson AA. 1995. Discrepancies in characterization of sigma sites in the mouse central nervous system. Eur J Pharmacol 285:127-134.
31. 125I]RTI-121). Nucl Med Biol 23:277-284.
32. 2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse 59:350-358.
33. Lever SZ, Xu R, Fan K-H, Fergason-Cantrell EA, Carmack TL, Watkinson LD, Lever JR. 2012. Synthesis, radioiododination and in vitro and in vivo sigma receptor studies of N-1-allyl-N'-4-phenethylpiperazine analogs. Nucl Med Biol 39:401-414.
34. Lever JR, Miller DK, Fergason-Cantrell EA, Green CL, Watkinson LD, Carmack TL, Lever SZ. 2014a. Relationships between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. J Pharmacol Exp Ther 351:153-163.
35. Lever JR, Miller DK, Green CL, Fergason-Cantrell EA, Watkinson LD, Carmack TL, Fan K-H, Lever SZ. 2014b. A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice. Synapse 68:73-84.
36. Lever JR, Litton TP, Fergason-Cantrell EA. 2015. Characterization of pulmonary sigma receptors by radioligand binding. Eur J Pharmacol 762:118-126.
37. Liu Y, Chen GD, Lerner MR, Brackett DJ, Matsumoto RR. 2005. Cocaine up-regulates fra-2 and σ-1 receptor gene and protein expression in brain regions involved in addiction and reward. J Pharmacol Exp Ther 314:770-779.
38. 1 receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: Time course and regional distribution studies. J Pharmacol Exp Ther 327:187-195.
39. 2 receptors. Life Sci 57:PL57-PL62.
40. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR. 1995. Characterization of two novel sigma receptor ligands: Antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 280:301-310.
41. 1 receptors produce anti-cocaine effects in mice. Eur J Pharmacol 419:163-174.
42. Matsumoto RR, Hewett KL, Pouw B, Bowen WD, Husbands SM, Cao JJ, Hauck Newman A. 2001b. Rimcazole analogs attenuate the convulsive effects of cocaine: Correlation with binding to sigma receptors rather than dopamine transporters. Neuropharmacol 41:878-886.
43. Matsumoto RR, McCracken KA, Pouw B, Zhang Y, Bowen WD. 2002. Involvement of sigma receptors in the behavioral effects of cocaine: Evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacol 42:1043-1055.
44. Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ. 2003. Sigma receptors: Potential medications development target for anti-cocaine agents. Eur J Pharmacol 469:1-12.
45. 2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice. Pharmacol Biochem Behav 86:86-91.
46. Matsumoto RR, Bowen WD, Su TP. 2007b. Sigma receptors: Chemistry, cell biology and clinical implications. New York: Springer.
47. Matsumoto RR, Nguyen L, Kaushal N, Robson MJ. 2014. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects. Adv Pharmacol 69:323-386.
48. 1 receptor in the appetitive effects of cocaine. Pharmacopsychiatry 37:198-207.
49. McCann DJ, Weissman AD, Su T-P. 1994. Sigma-1 and sigma-2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns. Synapse 17:182-189.
50. McCarthy LE, Mannelli P, Niculescu M, Gingrich K, Unterwald EM, Ehrlich ME. 2004. The distribution of cocaine in mice differs by age and strain. Neurotoxicol Teratol 26:839-848.
51. McCracken KA, Bowen WD, Matsumoto RR. 1999. Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine. Eur J Pharmacol. 365:35-38.
52. Menkel M, Terry P, Pontecorvo M, Katz JL, Witkin JM. 1991. Selective sigma ligands block stimulant effects of cocaine. Eur J Pharmacol 201:251-252.
53. 3 receptor complexes as key targets for reducing cocaine's effects. J Neurosci 34:3545-3558.
54. Nam Y, Shin EJ, Yang BK, Bach JH, Jeong JH, Chung YH, Park ES, Li Z, Kim KW, Kwon YB, Nabeshima T, Kim HC. 2012. Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors. Neurochem Int 61:913-922.
55. 1 receptor-mediated effects of cocaine. Proc Natl Acad Sci USA 107:18676-18681.
56. 2 receptor heteromers. PLoS One 8:e61245.
57. Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PR. 2015. The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci 16:305-312.
58. 2) receptors as a target for cocaine action in the rat striatum. Eur J Pharmacol 535:98-103.
59. 11C-SA4503 and microPET. Psychopharmacology (Berl) 231:3997-4006.
60. Ritz MC, George FR. 1993. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J Pharmacol Exp Ther 264:1333-1343.
61. Rodvelt KR, Lever SZ, Lever JR, Blount LR, Fan K-H, Miller DK. 2011. SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Pharmacol Biochem Behav 97:676-682.
62. 1 receptor in cocaine-induced conditioned place preference: Possible dependence on dopamine uptake blockade. Neuropsychophar Macology 26:444-455.
63. Rousseaux CG, Greene SF. 2015. Sigma receptors [σRs]: Biology in normal and diseased states. J Recept Signal Transduct Res June 9:1-62. [Epub ahead of print]
64. Ruth JA, Ullman EA, Collins AC. 1988. An analysis of cocaine effects on locomotor activities and heart rate in four inbred mouse strains. Pharmacol Biochem Behav 29:157-162.
65. Sage AS, Oelrichs CE, Davis DC, Fan K-H, Nahas RI, Lever SZ, Lever JR, Miller DK. 2013. Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice. Pharmacol Biochem Behav 110:201-207.
66. Sharkey J, Glen KA, Wolfe S, Kuhar MJ. 1988. Cocaine binding at sigma receptors. Eur J Pharmacol 149:171-174.
67. Sora I, Li B, Igari M, Hall FS, Ikeda K. 2010. Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs. Ann N Y Acad Sci 1187:218-246.
68. 125I]RTI-121. Synapse 21:364-372.
69. 123I]TPCNE - a novel SPET tracer for the sigma-1 receptor: First human studies and in vivo haloperidol challenge. Synapse 60:109-117.
70. 125I]RTI-121 quantitative autoradiography. Neurochem Int 32:61-68.
71. Thomsen M, Caine SB. 2011. Psychomotor stimulant effects of cocaine in rats and 15 mouse strains. Exp Clin Psychopharmacol 19:321-341.
72. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE. 1997. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830.
73. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC. 1990. Sigma receptors: Biology and function. Pharmacol Rev 42:355-402.
74. 123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine. J Med Chem 40:1657-1667.
75. Witkin JM, Terry P, Menkel M, Hickey P, Pontecorvo M, Ferkany J, Katz JL. 1993. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine. J Pharmacol Exp Ther 266:473-482.